Crossmark Global Holdings’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$56.9M Sell
513,021
-39,563
-7% -$4.39M 0.92% 14
2025
Q1
$61.9M Buy
552,584
+12,364
+2% +$1.39M 1.09% 8
2024
Q4
$49.9M Buy
540,220
+8,741
+2% +$807K 0.91% 15
2024
Q3
$44.6M Buy
531,479
+34,381
+7% +$2.88M 0.79% 15
2024
Q2
$34.1M Buy
497,098
+11,657
+2% +$800K 0.65% 20
2024
Q1
$35.6M Sell
485,441
-26,656
-5% -$1.95M 0.68% 20
2023
Q4
$41.5M Sell
512,097
-3,441
-0.7% -$279K 0.86% 10
2023
Q3
$39.2M Buy
515,538
+3,176
+0.6% +$241K 0.89% 10
2023
Q2
$39.4M Buy
512,362
+43,381
+9% +$3.33M 0.85% 9
2023
Q1
$38.9M Buy
468,981
+120,885
+35% +$10M 0.92% 6
2022
Q4
$29.9M Buy
348,096
+15,462
+5% +$1.33M 0.74% 15
2022
Q3
$20.5M Buy
332,634
+3,844
+1% +$237K 0.57% 26
2022
Q2
$20.3M Buy
328,790
+6,787
+2% +$419K 0.53% 29
2022
Q1
$19.1M Buy
322,003
+91,879
+40% +$5.46M 0.43% 42
2021
Q4
$16.7M Buy
230,124
+34,412
+18% +$2.5M 0.36% 59
2021
Q3
$13.7M Buy
195,712
+46
+0% +$3.21K 0.32% 74
2021
Q2
$13.5M Buy
195,666
+9,677
+5% +$666K 0.32% 72
2021
Q1
$12M Buy
185,989
+177
+0.1% +$11.4K 0.3% 83
2020
Q4
$10.8M Sell
185,812
-4,856
-3% -$283K 0.27% 86
2020
Q3
$12M Sell
190,668
-7,695
-4% -$486K 0.34% 67
2020
Q2
$15.3M Sell
198,363
-12,939
-6% -$996K 0.45% 36
2020
Q1
$15.8M Sell
211,302
-4,011
-2% -$300K 0.57% 31
2019
Q4
$14M Buy
215,313
+4,564
+2% +$297K 0.38% 61
2019
Q3
$13.4M Sell
210,749
-5,624
-3% -$356K 0.39% 56
2019
Q2
$14.6M Sell
216,373
-2,210
-1% -$149K 0.41% 47
2019
Q1
$14.2M Buy
218,583
+6,174
+3% +$401K 0.4% 48
2018
Q4
$13.3M Buy
212,409
+8,833
+4% +$552K 0.41% 46
2018
Q3
$15.7M Buy
203,576
+519
+0.3% +$40.1K 0.4% 47
2018
Q2
$14.4M Sell
203,057
-550
-0.3% -$39K 0.39% 48
2018
Q1
$15.4M Sell
203,607
-22,187
-10% -$1.67M 0.4% 46
2017
Q4
$16.2M Buy
225,794
+4,038
+2% +$289K 0.39% 48
2017
Q3
$18M Buy
+221,756
New +$18M 0.46% 40
2016
Q3
$18M Buy
+221,756
New +$18M 0.46% 40